US Patent 9732062 Therapeutically active compounds and their methods of use
Patent 9732062 was granted and assigned to Agios Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+178 characters)
Article
Patent abstract
Provided are compounds useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described herein.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Byron DeLaBarre0
Francesco G. Salituro0
Giovanni Cianchetta0
Janeta Popovici-Muller0
Jeffrey O. Saunders0
Jeremy Travins0
Li Zhang0
Shunqi Yan0
Tao Guo0
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09732062 Therapeutically active compounds and their methods of use US Patent 9732062 Therapeutically active compounds and their methods of use
Infobox
Patent Number
09732062
Patent Number
9732062
Edits on 14 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09732062 Therapeutically active compounds and their methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09732062
Date of patent
August 15, 2017
Patent application number
13735467
Date Filed
January 7, 2013
Patent primary examiner
Find more entities like US Patent 9732062 Therapeutically active compounds and their methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.